. Author manuscript; available in PMC: 2022 Mar 29.

Published in final edited form as: J Surg Oncol. 2021 Oct 27;125(3):475–483. doi: 10.1002/jso.26734

TABLE 2.

Primary and secondary outcomes by treatment strategy

Cumulative mortality	TAXa (N = 150)	RR (N = 1009)	p Value
Length of stay (days) (SD)	2.7 (13.6)	6.5 (8.1)	<0.001
30-day unplanned readmission, n (%)	5 (3.3)	62 (6.2)	0.16
30-day mortality, n (%)	0 (0.0)	9 (0.9)	0.20
90-day mortality, n (%)	1 (0.7)	18 (1.8)	0.06
1-year overall survival, n (%)	146 (97.3)	970 (96.1)	0.44
3-year overall survival, n (%)	135 (90.0)	906 (89.8)	0.68
5-year overall survival, n (%)	125 (83.3)	861 (85.3)	0.97

Abbreviations: RR, radical resection; TAXa, transanal excision with adjuvant therapy.